OQS
CINC

Occudo Quantitative Strategies’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Occudo Quantitative Strategies’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,155
Closed -$125K – 1294
2022
Q4 		$125K Buy
+10,155
New +$242K 0.01% 831

Occudo Quantitative Strategies's CINC Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 10,155 shares — an estimated $125K sold.

Occudo Quantitative Strategies first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $125K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 10,155 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $125K.
  • Occudo Quantitative Strategies first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's CinCor Pharma, Inc. Common Stock position peaked at $125K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.